In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection | Zendy

HyeKyung Cho | Zendy; Melissa J. Karau | Zendy; Kerryl E. GreenwoodQuaintance | Zendy; Karl A. Hansford | Zendy; Matthew A. Cooper | Zendy; Mark A. T. Blaskovich | Zendy; Robin Patel | Zendy

Open Access

In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection

Author(s) -

HyeKyung Cho,

Melissa J. Karau,

Kerryl E. GreenwoodQuaintance,

Karl A. Hansford,

Matthew A. Cooper,

Mark A. T. Blaskovich,

Robin Patel

Publication year - 2021

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.02443-20

Subject(s) - periprosthetic , joint infections , microbiology and biotechnology , staphylococcus aureus , vancomycin , methicillin resistant staphylococcus aureus , medicine , biofilm , in vitro , joint arthroplasty , daptomycin , staphylococcal infections , arthroplasty , biology , bacteria , surgery , biochemistry , genetics

MRSA periprosthetic 1 joint infection (PJI) can be challenging to treat due to biofilm formation, alongside sometimes limited vancomycin activity (1-3).….

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research